UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
5876
Autolus Therapeutics
AUTL
$562M
| $471K | ﹤0.01% |
200,232
+43,254
| +28% | +$146K |
|
5877
Aldeyra Therapeutics
ALDX
$93.5M
| $470K | ﹤0.01% |
94,275
+67,746
| +255% | +$348K |
|
5878
Invesco International Corporate Bond ETF
PICB
$362M
| $470K | ﹤0.01% |
21,799
-909
| -4% | -$20.3K |
|
5879
PACS Group
PACS
$7.67B
| $469K | ﹤0.01% |
35,791
+9,522
| +36% | +$244K |
|
|
HGLB
5880
Highland Global Allocation Fund
HGLB
$177M
| $468K | ﹤0.01% |
68,772
-4,232
| -6% | -$32.3K |
|
5881
Jayud Global Logistics
JYD
$7.73M
| $468K | ﹤0.01% |
2,926
+2,918
| +36,475% | +$189K |
|
5882
MediciNova
MNOV
$66M
| $468K | ﹤0.01% |
222,738
-82,751
| -27% | -$162K |
|
5883
FS Bancorp
FSBW
$320M
| $467K | ﹤0.01% |
11,371
+7,113
| +167% | +$318K |
|
5884
Acacia Research
ACTG
$470M
| $466K | ﹤0.01% |
107,487
+76,115
| +243% | +$345K |
|
|
NCZ
5885
Virtus Convertible & Income Fund II
NCZ
$301M
| $466K | ﹤0.01% |
37,256
+11,036
| +42% | +$140K |
|
5886
Medallion Financial
MFIN
$250M
| $466K | ﹤0.01% |
49,661
+28,849
| +139% | +$269K |
|
|
MRCC
5887
DELISTED
Monroe Capital Corp
MRCC
| $463K | ﹤0.01% |
54,457
-9,952
| -15% | -$81.9K |
|
5888
MaxCyte
MXCT
$126M
| $460K | ﹤0.01% |
110,646
+42,595
| +63% | +$161K |
|
5889
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$95.1M
| $459K | ﹤0.01% |
22,249
-1,056
| -5% | -$22.2K |
|
5890
Matrix Service
MTRX
$335M
| $459K | ﹤0.01% |
38,345
+5,944
| +18% | +$72.9K |
|
5891
Invesco FTSE RAFI Developed Markets ex-US Small-Mid ETF
PDN
$366M
| $456K | ﹤0.01% |
14,437
-4,343
| -23% | -$143K |
|
|
LX
5892
LexinFintech Holdings
LX
$241M
| $456K | ﹤0.01% |
78,639
+41,254
| +110% | +$173K |
|
5893
Johnson Outdoors
JOUT
$505M
| $455K | ﹤0.01% |
13,776
+7,836
| +132% | +$267K |
|
5894
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$174M
| $453K | ﹤0.01% |
9,213
+1,174
| +15% | +$59.3K |
|
5895
InterContinental Hotels
IHG
$23.2B
| $452K | ﹤0.01% |
3,617
+429
| +13% | +$51.4K |
|
5896
Direxion Daily Small Cap Bear 3x ETF
TZA
$210M
| $451K | ﹤0.01% |
3,480
-5,006
| -59% | -$611K |
|
5897
Blue Ridge Bankshares
BRBS
$332M
| $451K | ﹤0.01% |
140,144
+136,713
| +3,985% | +$431K |
|
5898
Invesco DB US Dollar Index Bullish Fund
UUP
$422M
| $451K | ﹤0.01% |
15,334
-4,359
| -22% | -$129K |
|
5899
ProShares VIX Short-Term Futures ETF
VIXY
$183M
| $450K | ﹤0.01% |
10,004
+4,984
| +99% | +$238K |
|
5900
Southern Missouri Bancorp
SMBC
$850M
| $450K | ﹤0.01% |
7,844
+1,471
| +23% | +$90.3K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.